SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-252347
Filing Date
2020-09-23
Accepted
2020-09-23 16:31:02
Documents
15
Period of Report
2020-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d61805d8k.htm   iXBRL 8-K 28342
2 EX-1.1 d61805dex11.htm EX-1.1 250487
3 EX-5.1 d61805dex51.htm EX-5.1 53746
4 EX-99.1 d61805dex991.htm EX-99.1 8704
8 GRAPHIC g61805dsp1.jpg GRAPHIC 3522
9 GRAPHIC g61805dsp2.jpg GRAPHIC 2478
  Complete submission text file 0001193125-20-252347.txt   551642

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wve-20200922.xsd EX-101.SCH 3091
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20200922_lab.xml EX-101.LAB 18071
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20200922_pre.xml EX-101.PRE 11399
10 EXTRACTED XBRL INSTANCE DOCUMENT d61805d8k_htm.xml XML 3332
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 201192345
SIC: 2834 Pharmaceutical Preparations